Gossamer Bio Inc. (GOSS) Tops Q1 EPS by 3c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $9.89 million versus the consensus estimate of $4.25 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• Trex (TREX) Reiterated at Hold by Benchmark as Partnership Agreement Announced
• Cal-Maine Foods (CALM) PT Lowered to $85 at Stephens